| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |